Product Information
METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by Mylan Institutional LLC, priced at $0.0371 per EA under NDC 51079088620. Its NADAC has been published 621 times since Aug 6, 2014.
Strength
5 mg/1
Manufacturer
Mylan Institutional LLCNDC
51079088620
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072801On Market Since
12/30/2013
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 621 times since Aug 6, 2014, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0371 per EA |
|---|---|
| All-time high | $0.0494 (May 13, 2015) |
| All-time low | $0.0357 (Nov 20, 2024) |
| 52-week high | $0.0433 |
| 52-week low | $0.0371 |
| Median price | $0.0428 |
| Average price | $0.0423 |
| Largest weekly change | -18.5% (Apr 17, 2024) |
| Weeks tracked | 621 |
| Tracking since | Aug 6, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by Mylan Institutional LLC, is $0.0371 per EA (NDC 51079088620), effective Jun 24, 2026.
How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 20.0%. It has been tracked across 621 weekly CMS publications since Aug 6, 2014.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?
Since Aug 6, 2014, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0357 (Nov 20, 2024) to a high of $0.0494 (May 13, 2015), with a median of $0.0428 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METOCLOPRAMIDE 5 MG TABLET, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG TABLET?
METOCLOPRAMIDE 5 MG TABLET (NDC 51079088620) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification